NOT KNOWN DETAILS ABOUT LEUKOTRIENE D4

), allows to explain why KIF15 will be able to facilitate resistance to Eg5 inhibitors in vivo. MT gliding driven by both of those mitotic motors was arrested only when they have been independently inhibited, lending assistance into the proposal that a mix drug therapy targeting these motors may be a workable approach for beating chemotherapeutic r